104 related articles for article (PubMed ID: 8597460)
21. Dehydroepiandrosterone sulfate decreases the interleukin-2-mediated overactivity of the natural killer cell compartment in senile dementia of the Alzheimer type.
Solerte SB; Fioravanti M; Schifino N; Cuzzoni G; Fontana I; Vignati G; Govoni S; Ferrari E
Dement Geriatr Cogn Disord; 1999; 10(1):21-7. PubMed ID: 9844034
[TBL] [Abstract][Full Text] [Related]
22. DHEAS as an effective vaccine adjuvant in elderly humans. Proof-of-principle studies.
Araneo B; Dowell T; Woods ML; Daynes R; Judd M; Evans T
Ann N Y Acad Sci; 1995 Dec; 774():232-48. PubMed ID: 8597462
[TBL] [Abstract][Full Text] [Related]
23. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
Vermeulen A; Kaufman JM; Giagulli VA
J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841
[TBL] [Abstract][Full Text] [Related]
24. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
[TBL] [Abstract][Full Text] [Related]
25. Biosynthesis of DHEAS by the human adrenal cortex and its age-related decline.
Hornsby PJ
Ann N Y Acad Sci; 1995 Dec; 774():29-46. PubMed ID: 8597467
[No Abstract] [Full Text] [Related]
26. The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor.
Majewska MD; Demirgören S; Spivak CE; London ED
Brain Res; 1990 Aug; 526(1):143-6. PubMed ID: 1964106
[TBL] [Abstract][Full Text] [Related]
27. DHEA(S): the fountain of youth.
Leowattana W
J Med Assoc Thai; 2001 Oct; 84 Suppl 2():S605-12. PubMed ID: 11853289
[TBL] [Abstract][Full Text] [Related]
28. Dehydroepiandrosterone sulfate is positively correlated with soluble interleukin 2 receptor and soluble intercellular adhesion molecule in systemic lupus erythematosus.
Straub RH; Zeuner M; Antoniou E; Schölmerich J; Lang B
J Rheumatol; 1996 May; 23(5):856-61. PubMed ID: 8724298
[TBL] [Abstract][Full Text] [Related]
29. Relationship between insulin, insulin-like growth factor I, and dehydroepiandrosterone sulfate concentrations during childhood, puberty, and adult life.
Smith CP; Dunger DB; Williams AJ; Taylor AM; Perry LA; Gale EA; Preece MA; Savage MO
J Clin Endocrinol Metab; 1989 May; 68(5):932-7. PubMed ID: 2523898
[TBL] [Abstract][Full Text] [Related]
30. The development of effective vaccine adjuvants employing natural regulators of T-cell lymphokine production in vivo.
Daynes RA; Araneo BA
Ann N Y Acad Sci; 1994 Aug; 730():144-61. PubMed ID: 8080168
[TBL] [Abstract][Full Text] [Related]
31. Relationship of body fat percentage and fat distribution with dehydroepiandrosterone sulfate in premenopausal females.
Williams DP; Boyden TW; Pamenter RW; Lohman TG; Going SB
J Clin Endocrinol Metab; 1993 Jul; 77(1):80-5. PubMed ID: 8325963
[TBL] [Abstract][Full Text] [Related]
32. Photoaffinity labeling of peroxisome proliferator binding proteins in rat hepatocytes; dehydroepiandrosterone sulfate- and bezafibrate-binding proteins.
Sugiyama H; Yamada J; Takama H; Kodama Y; Watanabe T; Taguchi T; Suga T
Biochim Biophys Acta; 1997 May; 1339(2):321-30. PubMed ID: 9187253
[TBL] [Abstract][Full Text] [Related]
33. Dehydroepiandrosterone sulfate: kinetics of metabolism in normal young men and women.
Bird CE; Masters V; Clark AF
Clin Invest Med; 1984; 7(2):119-22. PubMed ID: 6236000
[TBL] [Abstract][Full Text] [Related]
34. Serum dehydroepiandrosterone sulfate levels as an individual marker.
Thomas G; Frenoy N; Legrain S; Sebag-Lanoe R; Baulieu EE; Debuire B
J Clin Endocrinol Metab; 1994 Nov; 79(5):1273-6. PubMed ID: 7962319
[TBL] [Abstract][Full Text] [Related]
35. Induction of peroxisomal enzymes by dehydroepiandrosterone: metabolic activation by sulfate conjugation.
Suga T; Tamura H; Watanabe T; Yamada J
Ann N Y Acad Sci; 1996 Dec; 804():284-96. PubMed ID: 8993551
[No Abstract] [Full Text] [Related]
36. The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells.
MacIndoe JH
Endocrinology; 1988 Sep; 123(3):1281-7. PubMed ID: 2969800
[TBL] [Abstract][Full Text] [Related]
37. Decreased serum level of dehydroepiandrosterone sulfate in postmenopausal women with ovarian cancer.
Heinonen PK; Koivula T; Pystynen P
Gynecol Obstet Invest; 1987; 23(4):271-4. PubMed ID: 2956173
[TBL] [Abstract][Full Text] [Related]
38. Dehydroepiandrosterone 3 beta-sulphate is an endogenous activator of the peroxisome-proliferation pathway: induction of cytochrome P-450 4A and acyl-CoA oxidase mRNAs in primary rat hepatocyte culture and inhibitory effects of Ca(2+)-channel blockers.
Ram PA; Waxman DJ
Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):753-8. PubMed ID: 8053899
[TBL] [Abstract][Full Text] [Related]
39. Relationship between humoral immunoaugmenting properties of DHEAS and IgD-receptor expression in young and aged mice.
Swenson CD; Gottesman SR; Belsito DV; Samanich KM; Edington J; Thorbecke GJ
Ann N Y Acad Sci; 1995 Dec; 774():249-58. PubMed ID: 8597463
[TBL] [Abstract][Full Text] [Related]
40. Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans via locally generated immunoreactive insulin-like growth factor I.
Solerte SB; Fioravanti M; Vignati G; Giustina A; Cravello L; Ferrari E
J Clin Endocrinol Metab; 1999 Sep; 84(9):3260-7. PubMed ID: 10487697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
